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A systematic review of all reported incidence and prevalence studies of population rates of subclinical psychotic
experiences reveals a median prevalence rate of around 5% and a median incidence rate of around 3%. A meta-
analysis of risk factors reveals associations with developmental stage, child and adult social adversity, psychoactive
drug use, and also male sex and migrant status. The small difference between prevalence and incidence rates,
together with data from follow-up studies, indicates that approximately 75–90% of developmental psychotic
experiences are transitory and disappear over time. There is evidence, however, that transitory developmental
expression of psychosis (psychosis proneness) may become abnormally persistent (persistence) and subsequently
clinically relevant (impairment), depending on the degree of environmental risk the person is additionally exposed
to. The psychosis proneness–persistence–impairment model considers genetic background factors impacting on a
broadly distributed and transitory population expression of psychosis during development, poor prognosis of which,
in terms of persistence and clinical need, is predicted by environmental exposure interacting with genetic risk.
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The psychosis continuum
Psychiatric morbidity in a population may be seen as a
function of the degree to which the distribution of a
continuous phenotype, measurable in both healthy
and ill individuals, is shifted towards higher values
(Fig. 1). There is a long-standing notion that the psy-
chosis phenotype is expressed at levels well below its
clinical manifestation, commonly referred to as psy-
chosis proneness, psychotic experiences, schizotypy or
at-risk mental states (Meehl, 1962 ; Siever et al. 1993 ;
Chapman et al. 1994 ; Claridge, 1997 ; Crow, 1998;
Kwapil, 1998 ; Verdoux et al. 1998a ; van Os et al. 2000 ;
Stefanis et al. 2002 ; Vollema et al. 2002; Yung et al.
2003). A psychosis continuum implies that the same
symptoms that are seen in patients with psychotic dis-
orders can be measured in non-clinical populations.
The assumption of this approach is that experiencing
symptoms of psychosis such as delusions and hal-
lucinations is not inevitably associated with the pres-
ence of disorder. The latter is thought to be dependent
on symptom factors such as intrusiveness, frequency
and psychopathological co-morbidities on the one
hand, and personal and cultural factors such as coping,
illness behaviour, societal tolerance and the degree of
associated developmental impairment on the other
(Johns & van Os, 2001). Thus, even though the preva-
lence of the clinical disorder is low, the prevalence of
the symptoms can conceivably be much higher.
What constitutes proof for a psychosis continuum?
Distributional validity: a simulation
Although the distinction between health and illness
makes intuitive sense, it can be readily shown that
most common illnesses cannot be entirely dichot-
omous in nature. Diseases caused by a single domi-
nant gene defect that is fully penetrant may exist as a
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truly dichotomous phenomenon. If nothing else influ-
ences the expression of the genetic defect, the disease
in question will have the same distribution as the
genetic defect itself (Fig. 2b). However, in the case of
multi-factorial diseases, such as psychiatric disorders,
where multiple interacting causes contribute to the
phenotypic distribution, it can be shown, using stat-
istical simulations (available on request), that the most
likely distribution is half-normal (Fig. 2c). It may be
argued that it would still be possible that multiple
interacting factors contribute to an underlying con-
tinuous biological abnormality that, when a certain
threshold is reached, gives rise to a dichotomous be-
havioural phenotype. Although this may be possible,
it is unlikely given the fact that the biological and cog-
nitive abnormalities associated with (the genetics of)
schizophrenia have all been demonstrated to behave
as linear risk indicators without evidence of threshold
effects (Jones et al. 1994a, b).
Psychopathological validity
The vast majority of patients with non-affective psy-
chotic disorder meet criteria for other DSM-IV
psychiatric disorders (Kessler et al. 2005). Psychotic
symptoms outside psychotic disorder show a similar
pattern of ‘co-morbidity ’ (van Os et al. 2000), sug-
gesting continuity in terms of psychopathological
associations. Psychotic disorders can be usefully re-
presented as variation in several correlated psycho-
pathological dimensions, in particular dimensions of
positive, negative and affective symptoms (Kitamura
et al. 1995 ; McGorry et al. 1998). Interestingly, sub-
clinical psychotic experiences and the related concept
of schizotypy show a similar pattern. Thus, subclinical
positive psychotic experiences are strongly associated
with the negative symptoms within the psychosis
phenotype (van Os et al. 2000), and emerging work
in general population samples suggests the existence
of similar correlated affective and non-affective
dimensions of the psychosis phenotype at the sub-
clinical level (Stefanis et al. 2002 ; Krabbendam et al.
2004). Similarly, it has been observed that in studies
using variably defined schizotypy scales to measure
the subclinical manifestations of the psychosis
phenotype, the dimensions of subclinical psychosis
closely resemble those that have been identified in
schizophrenia, thus suggesting psychopathological
continuity between the clinical and subclinical
phenotypes (Vollema & van den Bosch, 1995 ;
Gruzelier, 1996; Vollema & Hoijtink, 2000 ; Mata et al.
2003 ; Lewandowski et al. 2006).
Epidemiological validity
Epidemiological validity refers to the notion that evi-
dence with respect to the distribution of a construct of
interest within a population should be consistent with
the propositions that stem from the theoretical model
of that construct. A categorical model of psychosis
does not predict that the symptoms of psychosis are
more common than the clinical disorder. By contrast, a
continuummodel accommodates high-prevalence and
high-incidence rates of psychotic and psychosis-like
experiences. To address this contrast, we systemati-
cally reviewed evidence on the prevalence and inci-
dence of psychotic symptoms and experiences in the
general population.
Methods
We searched entries in the Medline database, with
publication years from 1950 to (7 August) 2007, to
identify the intersection of two sets of publications :
(1) those papers identified using the truncated key-
word search terms ‘delus ’, ‘hallucinat ’, ‘paranoi ’,
‘psychos ’, ‘psychot ’, ‘ schizophr ’ or ‘schizotyp’ ; and
(2) those papers identified using the keyword search
terms ‘ incidence ’, ‘prevalence’, ‘ sensitivity ’ or ‘speci-
ficity ’. This intersection set, containing 17 363 articles,
was then reduced to those that were limited to human
research and included one or more of the following
key phrases :
‘general population ’
‘normal population’, ‘normal individuals ’, ‘normal
sample ’
‘healthy population’, ‘healthy individuals ’, ‘healthy
sample ’
‘community individuals ’, ‘ community sample ’
‘nonpsychotic ’, ‘ survival ’, ‘ screening’, ‘ subclinical ’
This yielded 2442 potentially relevant papers. We then
searched each of these papers, first by reading the title
and subsequently, as necessary, the abstract and the
paper itself to identify papers that described studies
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Fig. 1. Relationship between continuous phenotype and
dichotomous disorder. The difference in prevalence of a
psychotic disorder between population A (high prevalence)
and population B (low prevalence) is shown in the graph as a
function of differences between A and B in the population
mean value of a continuous phenotype.
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of symptoms of psychosis in the general population.
The following inclusion and exclusion criteria were
applied:
Papers included in the meta-analysis were those
that : (a) reported a study of a general population
sample with complete data on at least 100 partici-
pants ; (b) reported exact incidence or prevalence rates
(or count data or scores from which rates could be
determined) for dichotomous (at item or instrument
level) psychosis outcomes (symptoms or experience of
or resembling hallucinations, delusions, or both) ; and
(c) were published as original research in or since 1950.
We searched citations within papers meeting these
criteria to identify other potentially eligible studies.
We excluded studies for which: (a) participants were
recruited through secondary or tertiary health services
(e.g. ophthalmology services), prisons, or aged-care
facilities ; (b) there was insufficient information to de-
termine a prevalence or incidence rate, a sample size,
or that inclusion criteria were met ; (c) more than 20%
of the participants were (likely to have been) aged
o65 years ; (d) outcome measures conflated psychosis
outcomes with other outcomes, such as hypomania or
depersonalization ; and (e) psychosis outcomes were
sleep-related (hypnopompic and hypnagogic) halluci-
nations.
From each article, we recorded a cohort name and
its characteristics (sampling population, recruitment
strategy, response rate, the actual or eligible age range
of participants, the mean age and its standard devi-
ation, the proportion of participants aged o65 years,
the proportion of males in the sample, and significant
inclusion and exclusion criteria), the key outcome
phenotype and the criteria used to determine outcome
[the name of the measurement instrument, the ad-
ministration format (self-report, lay interview, pro-
fessional interview, observer ratings) ; the number
of items of the instrument that were used; classes of
excluded experience (reports attributed to misunder-
standing, experience judged as realistic or plausible,
experience attributed to drugs or general medical
conditions, experiences judged to be inconsequential) ;
the number of affirmative responses required to reach
study threshold for outcome presence ; any frequency,
severity, or likelihood criterion required to reach
study threshold for outcome presence ; for composite
phenotype outcomes, such as those collapsing out-
comes across items measuring hallucinations and
delusions, the number of items representing each
phenotype in the measure ; the outcome interval] ;
how outcome data were handled (whether rates were
weighted to compensate for the sampling strategy or
not, whether the rate was of any affirmative response
or a mean item endorsement frequency), the rate de-
nominator, and the rate itself. We recorded as many
rates as possible for each paper and cohort, provided
these were not derived under identical conditions. The
psychosis outcomes were hallucinations, delusions,
and the combined or unsegregated reporting of these.
Analysis
Of the papers we searched, 47 met the inclusion and
exclusion criteria. These 47 articles reported data from
analyses of 35 participant cohorts and yielded 217 es-
timates of the prevalence or 1-year incidence of the
phenotypes (Table 1). The highest number of estimates
yielded by a single paper or cohort was 36 from the
Zurich Study of Young Adults (Ro¨ssler et al. 2007), a
longitudinal study with rates of three types of exper-
ience (hallucinations, delusions, and unsegregated) for
two severity levels (at least moderate, at least a little
bit), across six waves of data collection spanning 20
years. By contrast, nine cohorts provided a single
prevalence or incidence estimate. The median number
of rates per cohort was 4.
To summarize rate data, we adopted the graphical
approach to the analysis of epidemiological findings
that Saha et al. (2008) proposed. This approach does
not yield a summary meta-analytic or weighted mean
rate but has the advantage of conveying full infor-
mation about the variability in findings. It also has the
(a) (b) (c)
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Fig. 2. Expected phenotypic distribution of a disorder of multi-factorial interactive aetiology. (a) Shows a continuous and
normal distribution of a trait in the general population, much as would be expected in the case of, for example, weight or IQ.
(b) Shows a clear bimodal distribution, with the great majority of the population having negligible values of the trait, whereas
a very small proportion has extremely high values. (c) Depicts a continuous but only half-normal distribution, with the
majority of the population having very low values but a significant proportion also having progressively higher values.
A systematic review and meta-analysis of the psychosis continuum 3
Table 1. Cohorts and data sources included in the analysis of epidemiological validity
Cohort name or description Source(s) Index
Observed or median rate (n)
H D H/D
Aichi prefecture schoolchildren, Japan Yoshizumi et al. (2004) P 0.213 (1)
Christchurch Health and Development Study, New Zealand Fergusson et al. (2003) P 0.018 (2) 0.100 (2) 0.091 (2)
DSM-IV Symptoms Driven Diagnosis System for Primary
Care validation study
Olfson et al. (1996) P 0.012 (1) 0.009 (1) 0.010 (1)
Dunedin Multidisciplinary
Child Health and Development Study
McGee et al. (2000) P 0.106 (2) 0.162 (2) 0.082 (2)
Poulton et al. (2000) I 0.113 (1) 0.149 (2)
Early Developmental Stages of Psychopathology, Munich Spauwen et al. (2003, 2006a) P 0.046 (1) 0.157 (1) 0.165 (2)
I 0.078 (2)
Epidemiological Catchment Area Program, USA Eaton et al. (1991) P 0.083 (4) 0.029 (2) 0.034 (2)
Tien (1991) I 0.030 (2) 0.009 (1) 0.010 (3)
Tien & Anthony (1990)
Tien & Eaton (1992)
Greek National Basic Airforce Training Centre Stefanis et al. (2004) P 0.032 (1) 0.054 (1) 0.048 (1)
Icelandic birth cohort Lı´ndal et al. (1994) P 0.117 (2)
Israeli young adult cohort Stueve & Link (1998) P 0.403 (2)
Liverpool University students, UK Bentall & Slade (1985) P 0.153 (2)
Manhattan primary care survey Olfson et al. (2002) P 0.100 (1) 0.063 (1) 0.134 (8)
Mexican American Prevalence and Services Survey, Fresno, USA Vega et al. (2006) P 0.044 (1) 0.047 (2) 0.125 (4)
Murray State University students, USA Barrett & Etheridge (1992) P 0.225 (1)
Murray State University students, USA Posey & Losch (1983) P 0.228 (1)
National Psychiatric Morbidity Surveys of Great Britain Brugha et al. (2005) P 0.006 (2) 0.003 (2)
[Second] National Survey of Psychiatric Morbidity in Great Britain Johns et al. (2004) P 0.025 (2) 0.087 (2) 0.079 (4)
Wiles et al. (2006) I 0.006 (2) 0.025 (2) 0.029 (5)
[Fourth] National Survey of Ethnic Minorities, England and Wales Johns et al. (2002) P 0.026 (8)
National Survey of Mental Health and Well-Being, Australia Degenhardt & Hall (2001) P 0.017 (8)
Scott et al. (2006)
Netherlands Mental Health Survey and Incidence Study Bak et al. (2005) P 0.033 (1) 0.017 (1) 0.040 (5)
Hanssen et al. (2005) I 0.020 (1)
van Os et al. (2000)
North Florida household survey Schwab (1977) P 0.110 (1)
Pamplona cohort Lo´pez-Ilundain et al. (2006) P 0.177 (1)
Peters et al. Delusions Inventory, standardization study Peters et al. (1999a) P 0.252 (1)
Peters et al. Delusions Inventory – 21-item version, standardization study Peters et al. (2004) P 0.298 (1)
Sleep epidemiology survey across five nations Ohayon & Schatzberg (2002) P 0.016 (1)
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benefit of allowing the inclusion of more than one rate
per cohort. That is, because there is no requirement
that synthesized rates be independent, multiple rates
derived from non-identical conditions within a single
cohort (e.g. the observed rates of hallucinations across
different thresholds or assessment periods) can be in-
cluded in the graphical analysis.
Results
Estimates of the prevalence and 1-year incidence of
psychotic symptoms and experiences vary substan-
tially across cohorts and studies (Fig. 3 ; Tables 1 and
2). The median prevalence, overall, was 5.3%, but the
interquartile range (IQR) was 1.9–14.4%. For inci-
dence, the median rate was 3.1% and the IQR wasSo
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Fig. 3. Cumulative relative frequencies of (a) prevalences
(n=195) and 1-year incidence (n=22) rates, collapsed across
phenotypes and other variables, and (b) prevalence rates for
phenotypes hallucinations (n=72), delusions (n=54), and for
unsegregated hallucinations, delusions, or both (n=69).
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1.1–8.6%. Thus, regardless of whether phenotype
assessment was based on self-report, lay interview
or clinical interview, the prevalence and annual inci-
dence rates are much higher than the clinical pheno-
type of non-affective psychotic disorder.
The great majority of studies focused on prevalent
psychotic experiences with relatively few studies be-
ing able to define truly incident cases (Tien & Eaton,
1992 ; Henderson et al. 1998 ; Hanssen et al. 2005) or
possible incident cases (Spauwen et al. 2006b ; Wiles
et al. 2006). Similarly, few studies distinguished be-
tween psychotic experiences with clinical impact
(assessed, for example, measuring the level of asso-
ciated distress and/or help-seeking behaviour), albeit
not enough to diagnose a psychotic disorder, and
psychotic experiences without clinical impact (without
distress and/or help-seeking behaviour). The import-
ance of this distinction is highlighted in several ways.
First, the importance of the clinical versus subclinical
distinction is evidenced by quantitative differences in
associations with clinical and demographic variables
(van Os et al. 2000) and quantitative differences in the
rate of transition to complete psychiatric disorder
(Hanssen et al. 2005). Second, in the studies reviewed
here, the median prevalence of experience that has a
clinical impact was 1.5% (IQR 0.4–3.0%) whereas the
median rate derived without this or similar restric-
tions (e.g. on the number of experiences or frequency
or probability criteria) was 8.4% (IQR 3.5–20.9%). The
median rate of 1.5%, however, probably represents an
underestimate of the true prevalence because of the
large number of methodological, design and cohort
variables, in particular the use of brief screening instru-
ments that result in fewer psychotic symptoms elicited
(data not shown). Thus, in the largest two cohort
studies where the clinical–subclinical distinction was
specifically made, and a sufficiently large number of
items for the assessment of psychotic experiences was
used, the rates of clinically relevant symptoms were
4.2% and 3.8% respectively (van Os et al. 2000 ;
Dominguez et al., unpublished observations).
Therefore, a distinction can be usefully made (Fig. 4)
between true subclinical psychotic experiences (preva-
lence around 8%) and subclinical psychotic symptoms,
which are associated with a degree of distress and
help-seeking behaviour but do not necessarily amount
to clinical psychotic disorder (prevalence around 4%).
In studies where psychotic symptoms and psychotic
disorder are both measured, the cut-off between psy-
chotic symptoms and psychotic disorder co-depends
on the investigator. For example, in the US National
Comorbidity Study, high rates of psychotic exper-
iences were reported by a sample of around 10 000
in the US population (28%). Nevertheless, according
to the clinicians reviewing these data, the rate of
Table 2. Prevalence and incidence percentiles and quartiles for psychosis phenotypes
Phenotype n
Percentile
10th
25th
lower
quartile
50th
median
75th
upper
quartile 90th
Prevalence rates
Hallucinations 72 0.01 0.01 0.04 0.08 0.21
Delusions 54 0.00 0.01 0.06 0.17 0.25
Hallucinations/delusions 69 0.02 0.04 0.07 0.16 0.23
All prevalence rates 195 0.01 0.02 0.05 0.14 0.23
Incidence rates
Hallucinations 6 0.01 0.01 0.02 0.04 0.08
Delusions 5 0.01 0.01 0.04 0.11 0.16
Hallucinations/delusions 11 0.01 0.01 0.03 0.07 0.11
All incidence rates 22 0.01 0.01 0.03 0.09 0.11
Psychotic
disorder (3%)Psychotic
symptoms (4%)
Psychotic
experiences (8%)
Fig. 4. Psychosis : variation along a continuum.
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non-affective psychotic disorder was only 0.7%, and
based on variables such as psychiatric hospitalization,
antipsychotic treatment, enduring impairment,
thought disorder and long duration of illness (Kendler
et al. 1996). A similar cut-off was reported in the
Netherlands Mental Health Survey and Incidence
Study (NEMESIS), where the prevalences of psychotic
experiences and non-affective psychotic disorder data
were 17.5% and 0.4% respectively. These data suggest
that the cut-off for diagnosis, given a high prevalence
of psychotic experiences in the population, is in part
determined bywhat clinicians feel needsmedical treat-
ment. Although such a cut-off certainly has clinical
validity, it is unlikely that scientific validity is deter-
mined by perception of need for treatment. A useful
way to link clinical and non-clinical psychotic experi-
ences conceptually is provided by data indicating that
associated dimensions of distress and influence on
behaviour discriminate between patients and non-
patients (Peters et al. 1999a, b, 2004 ; Serper et al. 2005).
A factor of interest is the difference between self-
report and interviewer-based assessment. Thus, in
studies where the interviews were conducted by clin-
icians or where lay-interviews were followed by
clinical reassessment at the level of symptoms, the
likelihood of false positives is reduced compared to
studies using direct or lay-interviewer assessed self-
reports. Thus, in the Dunedin Multidisciplinary
Health and Development Study, child psychiatrists
interviewed 11-year-old children about hallucinatory
experiences, and reported a prevalence of 8% (McGee
et al. 2000) ; the proportion with any hallucinatory
or delusional experience was even higher at 17.2%
(Poulton et al. 2000). Similarly, in the German Early
Developmental Stages of Psychopathology (EDSP)
study (Wittchen et al. 1998 ; Lieb et al. 2000), the
Composite International Diagnostic Interview (CIDI)
was conducted by trained psychologists who were
allowed to probe with follow-up clinical questions. In
this sample, the prevalence of psychotic experiences
was also high at 17.5% (Spauwen et al. 2003).
In the NEMESIS, self-reports collected by lay-
interviewers using the CIDI were subsequently re-
assessed by clinicians (van Os et al. 2001). A distinc-
tion, described above, was made between psychotic
symptoms that were clinically relevant (associated
with distress and help-seeking behaviour) and symp-
toms that were subclinical (i.e. not clinically relevant
because there was no distress or help-seeking behav-
iour). Comparing the ratings between clinicians and
self-reports for clinically relevant symptoms revealed
that 37% of self-reports of definite or possible clini-
cally relevant symptoms were not rated as such by the
clinicians, suggesting that these were false positives.
However, when these ‘ false-positive ’ individuals
were followed for a period of 3 years, their risk of de-
veloping later, clinician-assessed psychotic disorder
was increased by a factor of 25 [odds ratio (OR) 27.5,
95% confidence interval (CI) 4.5–123.4] compared to a
factor of 50 in the ‘ true ’ positives (OR 46.1, 95% CI
4.6–236.5) (Bak et al. 2003). The explanation for this
result is that of the 37% that were re-rated by the
clinician as not having clinical symptoms, many still
had self-reports of subclinical psychotic experiences,
and it was these individuals that displayed a greatly
increased risk of developing future psychotic disorder.
In another study, self-reported positive and negative
psychotic experiences were validated against inter-
view-based measures and found to have good con-
current validity (Konings et al. 2006). These findings
therefore suggest that although clinician assessment
and self-report of psychotic symptoms may differ
on the assessment of clinical relevance, additional
validity may be gained if a combination of clinician
interview and self-report is applied, in terms of pre-
diction of transition to more severe psychotic states.
Nevertheless, studies using self-reports are likely to
generate many false-positive reports, which may bias
associations with third variables. For example, a per-
son living in an inner-city extremely deprived area
may be reporting ‘real-life ’ circumstances rather than
paranoid ideation.
Demographic validity
If the psychosis phenotype exists as a continuum, the
relationships that are observed between clinical dis-
order and demographic characteristics (e.g. sex, age,
ethnicity) should extend to subclinical experience. To
test this hypothesis, we meta-analysed ORs reported
in the body of literature identified above (Table 1).
Methods and analysis
Each paper reporting on the cohorts identified in
Table 1 was examined to find reports of the odds of
psychosis outcomes given the following demographic
characteristics : age, education (years, qualifications),
employment status, ethnicity and immigrant status,
income, marital status, and sex. A number of other
papers, excluded from the prevalence and incidence
meta-analysis because they did not contribute unique
information nevertheless met all other inclusion and
exclusion criteria, reported on the effects of exposure
to risk factors, and, consequently, were included in
this analysis (van Os et al. 2001, 2003 ; Arseneault et al.
2002 ; Goodwin et al. 2003 ; Janssen et al. 2003, 2004 ;
Maric et al. 2003 ; Spauwen et al. 2004, 2006b ;
Fergusson et al. 2005).
From each paper, we recorded the key demographic
exposure variable and the associated OR with its 95%
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CI. If multiple OR values were reported for identical
exposures, the most adjusted (corrected) OR was re-
corded. If there were multiple contrasts for the same
exposure variable (e.g. age 20–29 v. 50–59, and 30–39 v.
50–59, etc.), all OR values were recorded. If OR values
were not reported, where possible we derived OR
values from counts or rates that were reported. If the
paper reported analysing the effects of exposure to a
risk factor but no estimate of the effect was reported,
we recorded the non-reporting of the effect and the
result of the analysis (e.g. not significant, or significant
with direction OR>1, etc.). OR values for exposure
interactions (e.g. sex by age) were not recorded. We
also recorded or determined relative risk (RR) ratios
in the same manner for all possible cohorts and ex-
posure conditions.
The majority of exposure effects were reported as
OR values. Consequently, we used this index in all
further analyses. From the collated data, we selected
only one OR per cohort for each demographic vari-
able. Where multiple OR values were available, we
selected rates as follows. When a summary rate was
reported, from the collapsing of multiple subdivisions
of the exposure variable, this rate was used. In the
absence of a summary rate, we selected the median
OR. The median ratio and its 95% margin were found
by taking the inverse log of the median of the log-
transformed rates. Finally, when an RR but no OR was
available, we used the RR as a substitute for the OR
provided the reported prevalence or incidence of out-
come across the whole cohort was less than 10% and
provided inclusion of the RR did not significantly alter
the outcome of the analysis. Weighted meta-analytic
OR values, their 95% CIs, and heterogeneity statistics
were calculated from log-transformed OR values and
margins using the Stata METAN command (StataCorp,
2007).
Results
Schizophrenia is characterized by strong associations
with specific demographic characteristics including
younger age, male sex, single marital status, un-
employment and ethnic minority group (Driessen et al.
1998 ; Verdoux et al. 1998b ; Agerbo et al. 2004 ;
McGrath et al. 2004). The meta-analysis indicates that
similar associations are apparent for psychotic symp-
toms and experiences at the subclinical level (Table 3).
Specifically, the prevalence of subclinical psychosis
was greater among males, migrants, ethnic minorities,
unemployed, unmarried, and less educated people.
One result was not anticipated. The available data
suggest that there is no evidence of an association
between the prevalence of subclinical experience and
age (Table 3). However, we question the reliability of
this finding. Although studies of 13 cohorts reported
examining this association, sufficient data could be ex-
tracted from only five. Of the remaining eight studies,
four reported significant effects in the expected direc-
tion and none reported effects in the opposite direction
(i.e. greater prevalence among older participants). Of
the 13 studies, eight reported at least some evidence
that the prevalence of subclinical psychosis was higher
among younger participants ; none of the remaining
tests led to the rejection of the null hypothesis. Treat-
ing the results of these tests as binomial outcomes, the
probability of observing eight or more significant ef-
fects from 13 tests, given the null hypothesis and a
rejection criterion of p=0.05, is 4.0r10x8.
On the whole, the evidence from meta-analyses of
exposure to demographic variables strongly supports
the notion of continuity between subclinical and
clinical expressions of psychosis.
Aetiological validity
Non-genetic risk factors
If there is a continuum of psychosis, then it is likely
that at least some of the genetic and non-genetic causes
contributing to variation at the highest, disorder level
of the continuum also impact at lower levels. Some of
the non-genetic risk factors associated with schizo-
phrenia such as urbanicity (Krabbendam & van Os,
2005), ethnic minority status (Cantor-Graae & Selten,
2005), childhood trauma (Read et al. 2005) and canna-
bis (Henquet et al. 2005) may also impact on the rate of
subclinical psychotic experiences. Studies also suggest
that the same developmental window of some ex-
posures, for example the window of childhood/ado-
lescent development associated with exposure to
cannabis and urbanicity, also applies to the subclinical
domain. For example, exposure to urbanicity during
adolescence increases the risk for psychotic exper-
iences (Spauwen et al. 2004, 2006a), whereas adult ex-
posure up to age 74 years does not (Wiles et al. 2006).
To test whether similar associations exist with sub-
clinical psychosis, we meta-analysed ORs reported in
the body of literature identified above (Table 1) using
the same methodology as was used to explore demo-
graphic validity.
The results of the meta-analysis indicate that ex-
posure to cannabis, alcohol or other psychoactive
drugs was associated with significant higher preva-
lence of subclinical psychosis as well as incident ex-
perience of subclinical psychosis (Table 3). Likewise,
stressful or traumatic experience (major life events,
abuse, discrimination) also predicts greater odds
of prevalent and incident experience, and urbanicity
predicts greater odds of prevalent subclinical
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psychosis. The meta-analysis therefore indicates that
subclinical psychotic experiences are associated with
the same risk factors that apply to psychotic disorder,
again suggesting that there is aetiological continuity
between subclinical and clinical psychosis pheno-
types.
Genetic risk factors
Given the substantial level of familial clustering of
psychotic disorders (Kety et al. 1971 ; Kendler &
Gardner, 1997), researchers have investigated to what
degree the dimensions of the subclinical psychosis
phenotype are also transmitted independently in
families with one or more affected relatives. One study
reported co-clustering of clinical and subclinical psy-
chosis phenotypes in families (Kendler et al. 1993).
Vollema et al. (2002) reported that the score on the
positive dimension of a schizotypy questionnaire ad-
ministered to relatives of patients with psychotic dis-
orders corresponded to their genetic risk of psychosis.
Fanous et al. (2001) demonstrated that interview-based
positive and negative symptoms in schizophrenia
predicted their equivalent subclinical symptom
dimensions in non-psychotic relatives, implying an
aetiological continuum between the subclinical and
the clinical psychosis phenotypes.
The issue of familial clustering of the multi-dimen-
sional, subclinical manifestation of psychosis has also
been studied in general population twin samples,
without selection on the basis of family history of
psychotic disorder. Kendler & Hewitt (1992) studied
twins from the general population and concluded that
the variance in most self-report schizotypy scales, ex-
cept for perceptual aberration, involved substantial
genetic contributions. MacDonald et al. (2001) found in
their general population-based twin study only one
common schizotypy factor, mainly explained by per-
ceptual aberration, magical ideation, schizotypal cog-
nitions and, to a lesser extent, social anhedonia. The
common schizotypy factor was influenced by shared
environmental, non-shared environmental and poss-
ibly genetic effects. A general population female twin
study by Linney et al. (2003) showed that additive
genetic and unique environmental effects influenced
self-reported psychotic experiences. The multivariate
structural equation model generated two indepen-
dent latent factors, namely a positive (i.e. cognitive
Table 3. The impact of demographic and non-genetic factors on the odds of the expression of the psychosis phenotype
Variable
Prevalence Incidence
OR (95% CI) Observationsa x2 pb OR (95% CI) Observationsa x2 pb
Demographic factors
Younger age 1.02 (0.99–1.05) 0-3-2 [0-4-4] 17.9 0.001 0.93 (0.29–2.93) 0-1-0 [0-1-0] – –
Less education 1.24 (1.12–1.38) 0-1-2 [0-1-1] 1.65 0.437 1.52 (1.19–1.93) 0-1-1 [0-0-0] 1.36 0.244
Unemploymentc 1.63 (1.38–1.92) 0-1-2 [0-1-1] 4.11 0.128 1.30 (0.97–1.73) 0-2-0 [0-0-0] 0.52 0.469
Immigrant 1.20 (1.01–1.43) 0-2-0 [0-1-0] 0.17 0.684 – – 0 – –
Asian minority 0.56 (0.42–0.74) 1-1-0 [0-0-0] 0.07 0.795 – – 0 – –
Ethnic minorityd 1.81 (1.51–2.16) 0-3-2 [0-0-1] 0.34 0.987 1.25e (0.88–1.78) 0-1-0 [0-0-0] – –
Lower income 1.32 (1.14–1.52) 0-1-2 [0-0-1] 9.95 0.007 0.71 (0.33–1.53) 0-1-0 [0-0-0] – –
Not married 1.72 (1.46–2.02) 0-3-2 [0-0-1] 1.05 0.902 1.26 (0.39–4.04) 0-1-0 [0-0-1] – –
Male 1.12 (1.03–1.21) 0-10-2 [0-3-1] 38.31 0.000 0.96 (0.81–1.15) 0-2-0 [0-0-0] 6.23 0.013
Non-genetic factors
Alcohol 1.93 (1.49–2.50) 0-1-2 [0-0-0] 3.23 0.198 2.16 (1.42–3.29) 0-1-1 [0-0-0] 1.83 0.176
Cannabis 2.59 (2.04–3.27) 0-0-3 [0-0-2] 7.10 0.029 1.75 (1.35–2.26) 0-1-2 [0-0-0] 2.54 0.280
Other drugs 3.59 (2.44–5.28) 0-2-2 [0-0-2] 5.02 0.171 1.95 (1.30–2.94) 0-2-1 [0-0-0] 0.53 0.767
Stress or trauma 2.15 (1.82–2.54) 0-1-4 [0-0-0] 8.86 0.065 4.48 (2.02–11.63) 0-1-1 [0-0-0] 0.52 0.469
Urbanicity 1.25 (1.17–1.33) 0-1-4 [0-0-0] 9.07 0.059 0.68 (0.46–1.02) 1-1-0 [0-0-0] 2.33 0.127
OR, Odds ratio ; CI, confidence interval.
a Observations gives the number of cohorts included in the analysis [excluded from the analysis due to insufficient data],
using the format A-B-C [A-B-C] where A, B and C are the numbers of cohorts with the statistical outcomes OR<1,
OR=1 and OR>1 respectively.
b p value heterogeneity statistic.
c Under- and unemployment.
d Excluding Asian minority comparisons.
e Relative risk.
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disorganization, unusual experiences and delusional
ideation) and a negative dimension (i.e. cognitive dis-
organization and introvertive anhedonia), suggesting
different aetiological mechanisms for the various
scales of the subclinical psychosis phenotype (Linney
et al. 2003). In a recent, general population study using
both self-report and interview-based measures of
positive and negative dimensions of psychotic exper-
iences in 257 subjects belonging to 82 families, sig-
nificant family-specific variation for both positive and
negative subclinical psychosis dimensions were dem-
onstrated, with between-family proportions of total
variance between 10% and 40%. Thus, both the posi-
tive and the negative dimensions of subclinical psy-
chosis show familial clustering in samples unselected
for psychiatric disease (Hanssen et al. 2006). These
converging findings suggest that there is aetiological
continuity between the subclinical and the clinical
psychosis phenotype not only in families of patients or
twin pairs but also in unselected families sampled
from the general population.
Associations with cognition
Evidence that the neurocognitive deficits associated
with schizophrenia are also detectable at the sub-
clinical level, albeit to a much lesser degree, comes
from studies investigating healthy individuals at gen-
etically or psychometrically defined risk for schizo-
phrenia. First, studies in non-affected first-degree
relatives of patients with psychotic disorder have
consistently shown modest alterations in neurocogni-
tive performance (Faraone et al. 1995 ; Egan et al. 2001 ;
Krabbendam et al. 2001) that, according to a recent
meta-analysis, predominantly affect the domains of
verbal memory, executive functioning and, to a lesser
extent, attention (Sitskoorn et al. 2004). In the offspring
of parents with schizophrenia, impaired cognition,
particularly with regard to verbal memory, is one of
the more robust findings (Owens & Johnstone, 2006).
The second line of studies has mainly used schizotypy
instruments to define psychometric risk for schizo-
phrenia in non-clinical populations. These studies
have similarly found below-average cognitive per-
formance (Park et al. 1995; Dinn et al. 2002 ; Bergida &
Lenzenweger, 2006), although cognitive impairment
may not be generalized (Lenzenweger & Gold, 2000 ;
Johnson et al. 2003) and may occur particularly in in-
teraction with genetic risk (Johnson et al. 2003). Many
studies have been carried out in patients with schizo-
typal personality disorder (Lenzenweger & Korfine,
1994 ; Voglmaier et al. 2000 ; Neumann &Walker, 2003 ;
Matsui et al. 2004 ; Siever & Davis, 2004 ; Krabbendam
et al. 2005 ; Raine, 2006), again suggesting deficits in
verbal memory, executive functioning and attention,
but no generalized profile of impairment. Few studies
have investigated cognition in relation to subclinical
psychotic or psychosis-like experiences in the general
population (Lenzenweger & Korfine, 1994 ; Voglmaier
et al. 2000 ; Neumann & Walker, 2003 ; Matsui et al.
2004 ; Krabbendam et al. 2005 ; Simons et al. 2007).
These studies showed weak covariation of subclinical
psychosis and cognition both within subjects and be-
tween relatives.
In the realm of social cognition, the mechanisms and
biases that may underlie specific symptoms of psy-
chosis have also been shown to operate at lower levels
of the psychosis continuum, where they may similarly
be associated with the presence of subclinical psy-
chotic experiences. The evidence is most robust for
deficits in mentalizing (Langdon & Coltheart, 1999,
2004 ; Marjoram et al. 2006 ; Pickup, 2006), as well as for
probabilistic reasoning biases or jumping-to-conclu-
sions (Linney et al. 1998 ; Colbert & Peters, 2002 ; van
Dael et al. 2006), both in first-degree relatives of
patients with psychotic disorder and in individuals
with subclinical psychotic or psychosis-like exper-
iences or with psychometrically defined schizotypy.
There is less consistent evidence for other social-
cognitive mechanisms, such as the monitoring of one’s
own speech or actions (Laroi et al. 2005 ; Allen et al.
2006 ; Versmissen et al. 2007a, b) or an externalizing
attribution style (Levine et al. 2004 ; McKay et al. 2005 ;
Janssen et al. 2006), for which both inconclusive and
positive findings have been reported.
Community validity
One implication of the continuum hypothesis is that, if
a true continuum exists, then the mean psychosis level
of the entire population should predict the rate of
cases of psychotic disorder. This issue was examined
in the NEMESIS, in which the rate of psychotic ex-
periences and the rate of psychotic disorders were
assessed in a random population sample of 7076 in-
dividuals (van Os et al. 2001). In that study, five dif-
ferent levels of urbanicity of the place of residence
of the subjects were used to define five groups with
differences in the rate of psychotic disorder. The
study then examined to what degree the increase in
the rate of psychotic disorder with greater level of ur-
banicity would be accompanied by a similar increase
in the level of subclinical psychotic experiences. The
results, depicted in Table 4, revealed that as the rate of
psychotic disorder increased with greater level of ur-
banicity, the level of psychotic experiences in the
healthy population also increased in a similar dose–
response fashion. These results suggest that the rates
of psychotic disorder in a population are directly
related to the mean level of psychosis proneness of the
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healthy population, similar to the relationship be-
tween population mean blood pressure and rate of
hypertension, or the mean level of neurotic symptoms
and the rate of minor psychiatric disorder.
Predictive validity
Subclinical psychosis predicts clinical psychotic disorder
Arguably the most important aspect of the validity of
subclinical psychosis involves the argument that, if
there is a continuum, then dynamic transitions over
time from subclinical, non-prodromal manifestations
to full-scale psychotic disorder must occur over
shorter and longer periods of time. Several studies
have addressed this issue. The first was reported by
Chapman et al. (1994), demonstrating high rates of
psychotic outcomes in individuals who had rated high
on scales of magical ideation and perceptual aber-
ration 10 years earlier. The longest prospective inves-
tigation was the follow-up of the Dunedin Multi-
disciplinary Health and Development Study, in
which children who had reported psychotic exper-
iences at age 11 years were clinically assessed at age
26 years. The 16-year risk of developing schizo-
phreniform disorder associated with prevalent psy-
chotic experiences at age 11 was increased 16-fold
compared to children without psychotic experiences.
In terms of absolute risk, 25% of children with psy-
chotic experiences at age 11 developed schizophreni-
form disorder at age 26 over the 16-year follow-up
(Poulton et al. 2000). Similar results were reported by
Hanssen et al. (2005), who first followed up a sample of
7076 individuals for 1 year to identify new, incident
cases of psychotic experiences. In a second follow-up,
individuals with incident psychotic experiences were
followed for 2 years to identify transitions to psychotic
Table 4. Rate of psychotic disorder in relation to level of psychosis of the healthy population
Area address
densitya
Number
interviewed
Any psychotic
disorderb n (%)
Psychotic
symptom, narrow
definitionc
n (%)
Psychotic
symptom, broad
definitiond
n (%)
<500 1185 7 (0.59) 28 (2.36) 163 (13.76)
500–999 1610 15 (0.93) 45 (2.80) 223 (13.85)
1000–1499 1541 23 (1.49) 69 (4.48) 262 (17.00)
1500–2499 1497 28 (1.87) 82 (5.48) 303 (20.24)
o500 1242 34 (2.74) 71 (5.72) 286 (23.03)
a Greater levels of area address density indicate greater level of urbanicity.
b Any DSM psychotic disorder (affective and non-affective).
c Any psychotic experience accompanied by significant distress and/or
help-seeking behaviour.
d Any psychotic experience, regardless of distress and/or help-seeking behaviour.
PSY+
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PSY+ PSY+ 
Impairment
Environmental
exposures
(sensitization)
Psychosis
persistence
Psychosis
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Psychosis
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Fig. 5. Psychosis proneness–persistence–impairment model.
According to this model, developmental expression of
psychotic experience is common and mostly transitory.
However, psychotic experiences may become persistent
through a mechanism of psychological and biological
sensitization. Persistence in turn increases the probability of
onset of impairment and need for care.
Birth Adolescence Adulthood
Level of
psychosis
None
Subclinical,
‘schizotypal’
Psychotic
disorder
Old age
A
B
C
Fig. 6. Sensitization and onset of psychotic disorder. Person A
has ‘normal ’ developmental expression of subclinical
psychotic experiences (psychosis proneness) that are transient.
Person B has similar expression but longer persistence due to
additional but mild environmental exposure. Person C has
longer persistence due to severe repeated environmental
exposure and transition to clinical psychotic disorder with
significant impairment.
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disorder. In their study, the 2-year transition rate to
clinical psychotic disorder was 8%, representing a
greater than 60-fold increase in risk compared to those
without incident psychotic experiences. The 2-year
risk rose to 21% for those with multiple psychotic ex-
periences, and to 15% for those whose psychotic
experience had arisen in the context of significant
lowering of mood (Hanssen et al. 2005).
Most subclinical psychosis is transitory
Although the above studies suggest that subclinical
expressions of psychosis are indeed predictive of
future transition to clinical psychotic disorder, also im-
portant are the questions : (i) How many individuals
have subclinical psychotic experiences that remain
subclinical over time? and (ii) How many have sub-
clinical psychotic experiences that disappear over time?
Some studies were able to address this issue. Hanssen
et al. (2005) reported that of individuals with new, in-
cident subclinical psychotic experiences at baseline,
only 8% had persistence of the psychotic experiences
at the subclinical level whereas 84% no longer pre-
sented with any psychotic experiences. The remaining
8% made the transition to clinical disorder. In a later
study with a more limited screen for existing, preva-
lent psychotic experiences at baseline and a shorter
follow-up, the great majority of individuals with psy-
chotic experiences similarly did not persist (18-month
persistence rate of 30%; Wiles et al. 2006).
The data therefore suggest that subclinical psychotic
experiences are prevalent, but mostly self-limiting and
of good outcome, although a small proportion go on to
develop a clinical psychotic disorder.
Clinical implications : the psychosis
proneness–persistence–impairment model
An important observation is that studies have dem-
onstrated that the generally good (because the symp-
toms are only transitory as described above) outcome
of subclinical psychotic experiences can be modified
to poorer outcomes of persistence and clinical need
for care if subjects are exposed to additional (proxy)
environmental risk factors. Examples of these are
trauma (Spauwen et al. 2006b), cannabis (Henquet et al.
2005) and urbanicity (Spauwen et al. 2004, 2006a).
This fact, together with the above discussed findings
of a high prevalence of psychotic experiences, their
familial clustering, age-associated expression and
low rate of transition to psychotic disorder, suggests
a model of psychosis that considers genetic back-
ground factors impacting on a broadly distributed and
transitory population expression of psychosis during
development, the poor prognosis of which, in terms
of persistence and clinical need, is predicted by en-
vironmental exposures interacting with genetic risk. In
other words, transitory developmental expression of
psychosis may become abnormally persistent and
clinically relevant depending on the degree of en-
vironmental risk the person is additionally exposed to
(Fig. 5). The phenomenon of persistence and sub-
sequent development of impairment and need for
care, that is : a diagnosable psychotic disorder, may be
related to processes of biological and psychological
sensitization, reviewed elsewhere (Collip et al. 2008),
and explain differences in longitudinal trajectories of
psychosis proneness as depicted in Fig. 6. Two studies
to date have attempted to specifically falsify elements
of the psychosis proneness–persistence–impairment
model. One focused on the stage from psychosis
proneness to psychosis persistence (Cougnard et al.
2007), and the other on the stage from psychosis per-
sistence to psychosis impairment (Dominguez et al.,
unpublished observations). The findings of both
studies are in agreement with the proneness–persist-
ence–impairment model of the onset of psychotic dis-
order ; a significant proportion of psychotic disorder
may be conceptualized as the rare poor outcome of a
common developmental phenotype characterized by
persistence of psychometrically detectable subclinical
psychotic experiences. The causes of psychotic dis-
order may thus be traced to the factors that make the
common and transitory developmental expression of
subclinical psychosis persist, highlighting the import-
ance of existing efforts at early detection and inter-
vention.
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